Viewing Study NCT02034968


Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-03-01 @ 6:00 AM
Study NCT ID: NCT02034968
Status: WITHDRAWN
Last Update Posted: 2015-03-05
First Post: 2014-01-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma
Sponsor: Zhejiang University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage IV Esophageal Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nimotuzumab View
None Nab-Paclitaxel View
None Carcinoma of Esophagus View